Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Lupin Limited is recalling 3,192 bottles of Escitalopram Tablets USP 20 mg because the labels may have incorrect or missing lot and expiration dates.
Lupin Pharmaceuticals is recalling 20,556 bottles of Lisinopril 30 mg tablets because they were manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Hospira Inc. is recalling 24,000 vials of Dobutamine Injection due to reports of product discoloration and particulates. The affected lot was distributed nationwide and to Puerto Rico and the Bahamas.
Aurobindo Pharma USA is recalling specific bottles of Pantoprazole Sodium Delayed-Release Tablets because a foreign tablet was found inside the container.
Amerisource Health Services is recalling 2,626 bottles of bupropion hydrochloride extended-release tablets due to failed dissolution specifications.
Amerisource Health Services is recalling 126 cartons of amphetamine extended-release capsules due to unit dose mispackaging where blister cavities may contain multiple capsules.
Allergy Laboratories is recalling Ephedrine Sulfate Injection vials because an FDA inspection raised concerns about product sterility.
Amerisource Health Services is recalling 115 cartons of 25 mg amphetamine extended-release capsules due to unit dose mispackaging where blister cavities may contain more than one capsule.
Amerisource Health Services is recalling 2,276 cartons of 10 mg amphetamine tablets because blister cavities may contain more than one tablet.
Teva North America is voluntarily recalling 92,480 containers of Linezolid Injection 600 mg/300 mL due to CGMP deviations. The recall covers products distributed nationwide and in Puerto Rico.
Amerisource Health Services is recalling 156 cartons of 30 mg amphetamine tablets because blister cavities may contain more than one tablet.
Pharmavite is recalling specific lots of Nature Made Super B-Complex due to possible Staphylococcus aureus contamination.
Amerisource Health Services is recalling 1,416 cartons of 15 mg amphetamine tablets because blister cavities may contain more than one tablet.
Amerisource Health Services is recalling 834 cartons of amphetamine extended-release capsules because blister cavities may contain more than one tablet or capsule.
Pharmavite is recalling specific lots of Nature Made Multi + Omega-3 supplements due to possible Salmonella contamination. Consumers should stop using the affected products.
Amerisource Health Services is recalling 867 cartons of 20 mg amphetamine tablets due to unit dose blister cavities containing more than one tablet.
Pharmavite is recalling Nature Made Super B-Complex vitamins due to possible Staphylococcus aureus and Salmonella contamination in specific lots.
Pharmavite is recalling Nature Made Super B-Complex supplements due to possible Staphylococcus aureus and Salmonella contamination in specific lots.
Zydus Pharmaceuticals is recalling 14,808 bottles of Bromocriptine Mesylate 5 mg capsules because stability samples failed impurity tests.
Amerisource Health Services is recalling 221 cartons of mixed amphetamine tablets due to unit dose mispackaging, where blister cavities may contain more than one tablet.
Teva North America is voluntarily recalling 1,299 bags of Argatroban Injection due to Current Good Manufacturing Practice (CGMP) deviations.
Lupin Limited is recalling Amlodipine Besylate tablets because they were manufactured using active pharmaceutical ingredients that failed specifications.
Pharmavite is recalling specific lots of Nature Made Vitamin D tablets because they may exceed specifications for yeast and mold.
Pharmavite is recalling specific lots of Nature Made Vitamin D tablets because they may exceed specifications for yeast and mold.
Teva North America is voluntarily recalling 14,661 vials of Eptifibatide Injection due to CGMP deviations. The recall covers lots distributed nationwide and in Puerto Rico.